These results suggest that in patients with impaired glucose tolerance an interaction between GAL and insulin occurs, thus they can promote a mutual secretion/synthesis inhibition, and that the enhanced GAL serum level could be used as a biomarker for the prediction of impaired glucose tolerance (Table 3). The gene discussed is INS; the disease is Impaired glucose tolerance.